SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant volatility following earnings results that beat top and bottom-line estimates but revealed deep-seated concerns regarding soft consumer demand in China and lackluster innovation. The community is sharply divided, with bulls pointing to the company's iconic brand status and potential for a long-term turnaround, while bears are aggressively shorting the stock, citing stagnant growth, a loss of market share to rising competitors, and skepticism toward management's long-term strategy.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors rotate into undervalued software companies, with many market participants viewing the stock as a critical 'orchestration layer' for safely monetizing and governing enterprise AI. The community is heavily focused on the high short interest and aggressive share buybacks, leading to ongoing speculation that these factors are priming the stock for a potential short squeeze.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is experiencing significant volatility as market participants weigh potential competitive pressure from new industry stablecoin consortia against long-term bullish expectations tied to the upcoming Clarity Act. While the community remains divided between those capitalizing on the dip as a long-term accumulation opportunity and those frustrated by recent technical weakness and insider selling, the stock continues to be heavily influenced by its status as a high-beta proxy for broader crypto-market sentiment and regulatory developments.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is seeing intense community debate as investors weigh strong brand loyalty and international growth prospects against concerns over recent stock performance, management communication, and increased sector competition. While many investors are positioning for a potential recovery driven by strategic distribution partnerships, world-class growth trends, and heavy short interest, others remain cautious due to volatile price action and broader sector rotation risks.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as shareholders react to a record-breaking delivery performance and strong brand growth, despite broader market skepticism and institutional selling pressure. Investors are actively debating whether these strong fundamentals will finally catalyze a sustained recovery or if the stock will remain trapped by geopolitical concerns and algorithmic trading.

Cantor Equity Partners II, Inc. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded on November 11, 2020 and is headquartered in New York, NY.

Cantor Equity Partners II Inc. - Ordinary Shares - Class A

Cantor Equity Partners II Inc

Cantor Equity Partners II is gaining momentum as investors anticipate its merger with Securitize, a leader in institutional-grade real-world asset (RWA) tokenization backed by firms like BlackRock and Morgan Stanley. The community is focused on the upcoming ticker change to SECZ, viewing it as a pivotal infrastructure play for tokenized equities and stablecoins as the sector shifts toward regulated, on-chain financial services.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is currently generating significant market attention due to its expanding partnership with Jazz Pharmaceuticals to develop next-generation T-cell engager therapies, a move seen by the community as a major validation of its drug discovery platform. Investors are closely monitoring upcoming clinical trial readouts, viewing the company's proprietary technology and robust cash position as key indicators of its long-term potential in the AI-driven biotech sector.

Alcoa Corp. engages in the bauxite mining, alumina refining, and aluminum smelting and casting. It operates through the Alumina and Aluminum segments. The Alumina segment consists of a refining system, including the mining of bauxite, which is then refined into alumina, a compound of aluminum and oxygen that is the raw material used by smelters to produce aluminum metal. The Aluminum segment is composed of smelting and casthouse system. The company was founded by Charles Martin Hall on July 9, 1886 and is headquartered in Pittsburgh, PA.

Alcoa Corp

Alcoa (AA) is gaining significant traction as investors bet on aluminum supply constraints, exacerbated by production-risk stories in the Middle East and strategic efforts to monetize power-intensive assets for the data center buildout. The community is actively debating the stock's cyclical patterns and long-term demand drivers, with many focusing on the potential for institutional accumulation despite recent volatility and energy-related margin pressures.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology and the broader memory sector are experiencing significant volatility as investors weigh the tension between unprecedented AI-driven storage demand and recent management commentary regarding capacity expansion constraints. Market sentiment remains split, with bulls focused on structural supply shortages and long-term cycle growth, while bears emphasize valuation concerns and potential cyclical risks.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp. is trending due to broad institutional momentum across the semiconductor equipment sector, fueled by synchronized institutional buying and strong expectations for AI infrastructure and memory capacity expansion. While some market participants are expressing concerns about overextended valuations and sector-wide repricing risks, community discussion remains heavily focused on the stock's role as a critical bottleneck in the fabrication supply chain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On

Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On...

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates

Aclaris (ACRS) delivered earnings and revenue surprises of +7.24% and +46.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Aclaris Therapeutics (NASDAQ:ACRS) Stock Rating Upgraded by Guggenheim

Guggenheim upgraded Aclaris Therapeutics to a "strong-buy" rating in a research report on Monday...

Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates

Rigel (RIGL) delivered earnings and revenue surprises of -40.54% and -2.39%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Aclaris Therapeutics Updates ATI-052 Phase 1 Data, Picks ATI-2138 for Phase 2b in Lichen Planus

Aclaris Therapeutics (NASDAQ:ACRS) provided a clinical program update on Tuesday, highlighting full top-line results from its phase I-A single-ascending dose (SAD) and multiple-ascending dose (MAD...

Aclaris Therapeutics (NASDAQ:ACRS) Major Shareholder Sells $1,359,000.00 in Stock

Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) major shareholder Braden Michael Leonard sold 300,000 shares of Aclaris Therapeutics stock in a transaction on Thursday, April 23rd. The...

Aclaris Therapeutics (NASDAQ:ACRS) Major Shareholder Braden Michael Leonard Sells 300,000 Shares

Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) major shareholder Braden Michael Leonard sold 300,000 shares of the stock in a transaction on Thursday, April 23rd. The shares were sold at...

Aclaris Therapeutics (NASDAQ:ACRS) Shares Gap Down - Here's What Happened

Aclaris Therapeutics (NASDAQ:ACRS) Shares Gap Down - Time to Sell...

Aclaris Therapeutics Touts ATI-052 Potential for 3-Month Dosing, More Phase 1 Data Incoming

Aclaris Therapeutics (NASDAQ:ACRS) used an H.C. Wainwright inflammatory skin diseases conference fireside chat to outline development plans and differentiation points for its lead biologic candidate...

Short Interest in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Increases By 49.4%

Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totaling 7,017,767 shares, an increase of 49.4% from the March 15th total of 4,697,214 shares. Based on an average...

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Aclaris Therapeutics Inc

Aclaris Therapeutics Stock Surges On Licensing Deal, $80 Million Private Placement: Retail Sentiment Jumps

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$5.29
Prev Close	$5.02
Open	$4.99
Dividend Yield	0.00%
50-Day Moving Average	$4.57
Beta	1.21
Avg. Volume	1.15M
PE Ratio	-9.44

52-Week High	$5.35
52-Week Low	$1.39
Market Capitalization	$701.11M
EPS (Annual)	-$0.5297
Price to Book	5.14
Revenue Per Employee	$107,205.48

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACRSAclaris Therapeutics Inc

Latest ACRS News